AU3269793A - Method for obtaining recombinant surface antigen of hepatitis B, antigen and vaccine based on it - Google Patents

Method for obtaining recombinant surface antigen of hepatitis B, antigen and vaccine based on it

Info

Publication number
AU3269793A
AU3269793A AU32697/93A AU3269793A AU3269793A AU 3269793 A AU3269793 A AU 3269793A AU 32697/93 A AU32697/93 A AU 32697/93A AU 3269793 A AU3269793 A AU 3269793A AU 3269793 A AU3269793 A AU 3269793A
Authority
AU
Australia
Prior art keywords
antigen
hepatitis
vaccine based
obtaining recombinant
recombinant surface
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU32697/93A
Other languages
English (en)
Inventor
Andrei Gennadievich Amosov
Vera Nikolaevna Borisova
Mikhail Valentinovich Budanov
Igor Viktorovich Krasilnikov
Lidiya Anatolievna Mikhailova
Mikhail Alexeevich Novikov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gensci Ltd
Original Assignee
Gensci Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SU5025798/14A external-priority patent/RU2045073C1/ru
Priority claimed from SU5025861/14A external-priority patent/RU2045760C1/ru
Application filed by Gensci Ltd filed Critical Gensci Ltd
Publication of AU3269793A publication Critical patent/AU3269793A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5761—Hepatitis B
    • G01N33/5764—Hepatitis B surface antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU32697/93A 1991-12-27 1992-12-25 Method for obtaining recombinant surface antigen of hepatitis B, antigen and vaccine based on it Abandoned AU3269793A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SU5025798/14A RU2045073C1 (ru) 1991-12-27 1991-12-27 Способ получения рекомбинантного поверхностного антигена гепатита в
SU5025861/14A RU2045760C1 (ru) 1991-12-27 1991-12-27 Способ получения рекомбинантного поверхностного антигена гепатита в
CN93101738A CN1090324A (zh) 1991-12-27 1993-01-20 乙型肝炎重组体表面抗原的制备方法及以其为基的抗原和疫苗

Publications (1)

Publication Number Publication Date
AU3269793A true AU3269793A (en) 1993-07-28

Family

ID=36793879

Family Applications (1)

Application Number Title Priority Date Filing Date
AU32697/93A Abandoned AU3269793A (en) 1991-12-27 1992-12-25 Method for obtaining recombinant surface antigen of hepatitis B, antigen and vaccine based on it

Country Status (3)

Country Link
CN (1) CN1090324A (fr)
AU (1) AU3269793A (fr)
WO (1) WO1993012815A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100443117C (zh) * 2003-05-13 2008-12-17 深圳康泰生物制品股份有限公司 一种治疗性乙型肝炎的疫苗制剂、其制备方法及其用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4769238A (en) * 1981-08-04 1988-09-06 The Regents Of The University Of California Synthesis of human virus antigens by yeast
NZ201705A (en) * 1981-08-31 1986-03-14 Genentech Inc Recombinant dna method for production of hepatitis b surface antigen in yeast
JPS60193925A (ja) * 1984-03-13 1985-10-02 Chemo Sero Therapeut Res Inst 凍結乾燥製剤化ワクチン
FI861417A0 (fi) * 1985-04-15 1986-04-01 Endotronics Inc Hepatitis b ytantigen framstaelld med rekombinant-dna-teknik, vaccin, diagnostiskt medel och cellinjer samt foerfaranden foer framstaellning daerav.
JPH089637B2 (ja) * 1986-06-18 1996-01-31 財団法人阪大微生物病研究会 Ｂ型肝炎ウイルス抗原とその製造法
FR2608052B1 (fr) * 1986-12-10 1990-04-13 Pasteur Vaccins Procede de preparation d'un vaccin contre l'hepatite b et vaccin obtenu
FR2635532B1 (fr) * 1988-07-29 1992-05-22 Pasteur Institut Particules hbsag recombinantes hybrides : caracteristiques morphologiques de l'antigene hbsag contenant 1 sequence immunogene induisant des anticorps neutralisants diriges contre hiv ou susceptible d'etre reconnue par de tels anticorps; sequences nucleotidiques codant pour de telles particules; vaccins les contenant
GB9007024D0 (en) * 1990-03-29 1990-05-30 Imperial College Novel vaccine

Also Published As

Publication number Publication date
WO1993012815A1 (fr) 1993-07-08
CN1090324A (zh) 1994-08-03

Similar Documents

Publication Publication Date Title
AU9052091A (en) Vaccines based on hepatitis b surface antigen
AU709406C (en) Combined vaccines comprising hepatitis B surface antigen and other antigens
AU6304996A (en) Vaccines against hepatitis c
ZA97721B (en) Methods for retreatment of patients afflicted with hepatitis C using consensus interferon.
GB9324607D0 (en) Hepatitis c diagnostics and vaccines
AU1471797A (en) Hybrid protein between CS from plasmodium and HBsAG
GB2264949B (en) Measles virus recombinant poxvirus vaccine
AU7237391A (en) Carrier-bound recombinant protein, process for producing it and its use as an immunogen and vaccine
AU1631188A (en) Newcastle disease virus vaccine and method for the application thereof
AU1459792A (en) Basic structural immunogenic polypeptides having epitopes for hcv, antibodies, polynucleotide sequences, vaccines and methods
AU2981395A (en) Method of identifying and producing antigen peptides and use thereof as vaccines
EP0586065A3 (en) Antigenic peptides for grouping hepatitis c virus, kit comprising the same and methods for its grouping using the same
AU3597089A (en) Method for producing nonhyperglycosylated hepatitis b virus proteins
AU2370592A (en) Epitopes of the env protein of the hepatitis c virus
AU3269793A (en) Method for obtaining recombinant surface antigen of hepatitis B, antigen and vaccine based on it
AU1522792A (en) Multiple hepatitis b virus surface proteins which form particles
AU3232995A (en) Hepatitis a virus deletion mutants and vaccine formulations containing the same
AU2971692A (en) Flystrike antigen and vaccine and method for preparation
AU7909391A (en) Epitopes of the pre-s region of hepatitis b virus surface antigen
ZA932210B (en) A process for preparation of a recombinant hepatitis B surface antigen, and antigen and vaccine based thereon
AU5873094A (en) Multivalent ab1 antibodies as vaccines
AU1668788A (en) Method of vaccination for hepatitis b virus
GR3036125T3 (en) Recombinant proteins having the immunoreactivity of Hepatitis B virus e antigens (HBeAg), method for their production and their application in immunoassays and as vaccines.
HK1001542A1 (en) Hepatitis e virus vaccine and method.
AU6769594A (en) Hepatitis c virus immunodiagnostic antigens and antibodies